CABG – Medxy AI

CABG Provides Superior Long-Term Outcomes to PCI in Women with Chronic Severe CAD: Real‑World Ontario Cohort Shows Lower MACCE and Mortality

By MedXY 11/28/2025

In a propensity‑matched Ontario cohort of women with chronic severe coronary artery disease, CABG was associated with lower long‑term MACCE and all‑cause mortality than PCI over a median 5.1 years.

Cardiology Clinical Updates news

Intravascular Imaging-Guided PCI vs CABG for Left Main or 3-Vessel Disease: Bridging the Outcome Gap

By MedXY 09/22/2025

Recent study shows intravascular imaging-guided PCI may offer comparable 3-year outcomes to CABG in patients with left main or 3-vessel coronary disease, challenging prior assumptions favoring surgery.

Cardiology news Specialties

Comparing Health Status Outcomes of PCI and CABG in Chronic Coronary Disease: Insights from ISCHEMIA

By MedXY 09/05/2025

The ISCHEMIA trial reveals that both PCI and CABG improve health status over conservative management in chronic coronary disease, with CABG offering superior angina relief at 1 year but similar benefits to PCI by 3 years.

Cardiology Specialties

Comparative Effects of Nicorandil, Isosorbide Mononitrate, and Diltiazem on Radial Artery Graft Patency After CABG: Insights from the ASRAB-Pilot Trial

By MedXY 08/17/2025

The ASRAB-Pilot trial demonstrates that nicorandil and isosorbide mononitrate reduce radial artery graft failure rates post-CABG compared to diltiazem, highlighting potential advances in antispastic therapy for graft preservation.

Cardiology news Specialties

Assessing the Impact of Exenatide Infusion During Cardiopulmonary Bypass in CABG and Aortic Valve Replacement Surgery

By MedXY 08/17/2025

A randomized clinical trial found that exenatide infusion during and after cardiopulmonary bypass did not reduce death or major organ failure in low-risk patients undergoing coronary artery bypass grafting or aortic valve replacement.

Cardiology Clinical Updates news Specialties

Percutaneous versus Surgical Approaches in Aortic Stenosis with Complex Coronary Disease: TCW Trial Insights

By MedXY 08/02/2025

The TCW trial demonstrates that FFR-guided PCI plus TAVI is non-inferior and even superior to SAVR plus CABG in elderly patients with severe aortic stenosis and complex coronary artery disease.